About Pharmerit_WPadmin

This author has not yet filled in any details.
So far Pharmerit_WPadmin has created 242 blog entries.

Reducing Red Blood Cell Transfusion in Orthopedic and Cardiac Surgeries with Antifibrinolytics: A Laboratory Medicine Best Practice Systematic Review and Meta-Analysis

Reducing Red Blood Cell Transfusion in Orthopedic and Cardiac Surgeries with Antifibrinolytics: A Laboratory Medicine Best Practice Systematic Review and Meta-Analysis Objectives To evaluate the effectiveness of antifibrinolytics tranexamic acid [...]

2019-07-29T15:29:02-04:00July 24th, 2019|

A Quality-adjusted Time Without Symptoms or Toxicity (Q-TWiST) Analysis of Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma (aRCC)

A Quality-adjusted Time Without Symptoms or Toxicity (Q-TWiST) Analysis of Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma (aRCC) Background This analysis compared quality-adjusted time without symptoms of disease progression [...]

2019-07-31T13:12:15-04:00July 24th, 2019|

Restrictive Transfusion Strategy and Clinical Decision Support Practices for Reducing RBC Transfusion Overuse

Restrictive Transfusion Strategy and Clinical Decision Support Practices for Reducing RBC Transfusion Overuse Objectives Assess support for the effectiveness of two separate practices, restrictive transfusion strategy and computerized physician order [...]

2019-07-25T14:10:39-04:00July 24th, 2019|

Patient-Centered Outcomes in Schizophrenia Patients Treated with Once-Monthly Extended-Release Risperidone in a Long-Term Clinical Study.

Patient-Centered Outcomes in Schizophrenia Patients Treated with Once-Monthly Extended-Release Risperidone in a Long-Term Clinical Study Purpose RBP-7000 (PERSERIS™) is a once-monthly subcutaneous extended-release risperidone formulation approved by the United States [...]

2019-07-24T14:07:56-04:00July 24th, 2019|

Measuring Recovery in Opioid Use Disorder: Clinical Utility and Psychometric Properties of the Treatment Effectiveness Assessment.

Measuring Recovery in Opioid Use Disorder: Clinical Utility and Psychometric Properties of the Treatment Effectiveness Assessment. Purpose The Treatment Effectiveness Assessment (TEA) is a patient-centered instrument for evaluating treatment progress [...]

2019-07-02T07:40:40-04:00July 2nd, 2019|

Uncertainty and Cures: Discontinuation, Irreversibility, and Outcomes-Based Payments: What Is Different About a One-Off Treatment?

Payers are concerned that one-off “cures” bring great uncertainty with the consequential risk of incorrect adoption decisions, and significant budget impact from large one-off payments.

2019-06-19T12:42:31-04:00June 19th, 2019|

Comparison of Quality Of Life Measurements: EQ-5D-5L versus Disease/Treatment-Specific Measures in Pulmonary Embolism and Deep Vein Thrombosis.

Comparison of Quality Of Life Measurements: EQ-5D-5L versus Disease/Treatment-Specific Measures in Pulmonary Embolism and Deep Vein Thrombosis. INTRODUCTION There is a lack of performance comparisons of the generic quality of [...]

2019-06-12T12:48:30-04:00June 11th, 2019|